KFDA willing to lure multinational joint clinical trials

The Korea Food and Drug Administration (KFDA) unveiled its plan to actively attract the multinational joint clinical trials to Korea in a bid to improve the level of domestic clinical trials and acquire the foreign R&D new drug technologies.

Noting that Korea has so far been one of the unwelcome countries from foreign-invested pharmaceutical firms in line with the multinational joint clinica...